Original Publication Date: 6 June, 2014
Publication / Source: Future Oncology
Authors: Vijaya R Bhatt, Apar Kishor Ganti, James K Schwarz & Jue Wang
With 65,000 new cases in the USA in 2013, the incidence of kidney cancer has doubled in last decade and accounted for 13,600 deaths in 2013 [1,2]. Renal cell carcinoma (RCC), which consists of 80% of kidney cancers in adults , presents with advanced or metastatic stage in approximately a third of patients. A third of early-stage RCC will subsequently recur or progress to metastatic disease after initial nephrectomy .